4-{[4-(trifluoromethyl)phenyl]methyl}-2,3,4,5-tetrahydro-1,4-benzoxazepin-5-one

Catalog No.: 
ACXIBD805
CAS No.: 
866156-35-6
Molecular Formula: 
C17H14F3NO2
Molecular Weight: 
321.30
4-{[4-(trifluoromethyl)phenyl]methyl}-2,3,4,5-tetrahydro-1,4-benzoxazepin-5-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg90%$109.00InquiryInquiry
1g90%$323.00InquiryInquiry
5g90%$1583.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-{[4-(trifluoromethyl)phenyl]methyl}-2,3,4,5-tetrahydro-1,4-benzoxazepin-5-one
IUPAC Name4-(4-(trifluoromethyl)benzyl)-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one
MDL No.MFCD05669867
Molecular FormulaC17H14F3NO2
Molecular Weight321.30
SMILESO=C1N(CC2=CC=C(C(F)(F)F)C=C2)CCOC3=CC=CC=C13
InChI KeyAZONVJZDIGOQRW-UHFFFAOYSA-N
Synonym4-{[4-(trifluoromethyl)phenyl]methyl}-2,3,4,5-tetrahydro-1,4-benzoxazepin-5-one;1,4-Benzoxazepin-5(2H)-one, 3,4-dihydro-4-[[4-(trifluoromethyl)phenyl]methyl]-
CAS No.866156-35-6

Synthetic Route by SureRoute

1. ACXIBD805 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACCYRL054 route compound structure diagram
    ACCYRL054703-51-5In Stock
  4. Then
  5. ACXIBD805 route product structure diagram
    ACXIBD805866156-35-6
Inquiry

2. ACXIBD805 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACCYRL054 route compound structure diagram
    ACCYRL054703-51-5In Stock
  4. Then
  5. ACXIBD805 route product structure diagram
    ACXIBD805866156-35-6
Inquiry

3. ACXIBD805 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXIBD805 route product structure diagram
    ACXIBD805866156-35-6
Inquiry

Comments (0)